EFFECT OF PENTOXIFYLLINE ON CARBOHYDRATE-METABOLISM IN TYPE-II DIABETICS

被引:5
作者
AMBRUS, JL
STADLER, S
BANNERMAN, R
机构
关键词
D O I
10.1001/archinte.150.4.921
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:921 / 921
页数:1
相关论文
共 8 条
[1]   THE ROLE OF FIBRINOLYSIS IN THE THERAPY OF PERIPHERAL VASCULAR-DISEASE [J].
AMBRUS, CM ;
AMBRUS, JL ;
GASTPAR, H ;
SHARMA, SD ;
SUH, OW ;
MOORE, RH ;
WILLIAMS, P .
ANGIOLOGY, 1984, 35 (07) :436-442
[2]   RED-CELL FLEXIBILITY AND PLATELET-AGGREGATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE VASCULAR-DISEASE (COAD) AND STUDY OF THERAPEUTIC APPROACHES [J].
AMBRUS, JL ;
AMBRUS, CM ;
TAHERI, SA ;
GASTPAR, H ;
REDDINGTON, MM ;
TAHERI, P ;
KAHN, EA ;
SCHATTMAN, GL ;
DEAN, LS ;
MOORE, RH .
ANGIOLOGY, 1984, 35 (07) :418-426
[3]  
AMBRUS JL, IN PRESS DIABETES VA
[4]  
GASTPAR H, 1977, J MED, V8, P191
[5]  
MASIEWZKIJ AH, 1978, PHARMATHERAPEUTICA, V2, P105
[6]   24-H BLOOD-GLUCOSE PATTERN IN TYPE-I AND TYPE-II DIABETICS AFTER ORAL TREATMENT WITH PENTOXIFYLLINE AS ASSESSED BY ARTIFICIAL ENDOCRINE PANCREAS [J].
RAPTIS, S ;
MITRAKOU, A ;
HADJIDAKIS, D ;
DIAMANTOPOULOS, E ;
ANASTASIOU, C ;
FOUNTAS, A ;
MULLER, R .
ACTA DIABETOLOGICA LATINA, 1987, 24 (03) :181-192
[7]  
SCHUBOTZ R, 1976, PHARMATHERAPEUTICA, V1, P172
[8]  
SOLERTE SB, 1985, PHARMATHERAPEUTICA, V4, P341